Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
14.25
-0.01 (-0.04%)
Oct 14, 2025, 3:31 PM EDT - Market open
Immunome Market Cap
Immunome has a market cap or net worth of $1.24 billion as of October 14, 2025. Its market cap has increased by 43.98% in one year.
Market Cap
1.24B
Enterprise Value
976.50M
1-Year Change
43.98%
Ranking
Category
Stock Price
$14.25
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $1.24B, an increase of 1,013.16%. That is a compound annual growth rate of 61.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 1.24B | 87.13% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | 102.04M | -8.39% |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |